Supportive Care in Cancer

, Volume 24, Issue 6, pp 2627–2634 | Cite as

Helplessness/hopelessness, minimization and optimism predict survival in women with invasive ovarian cancer: a role for targeted support during initial treatment decision-making?

  • Melanie A. Price
  • Phyllis N. Butow
  • Melanie L. Bell
  • Anna deFazio
  • Michael Friedlander
  • Joanna E. Fardell
  • Melinda M. Protani
  • Penelope M. Webb
  • AOCS—Quality of Life Study Investigators on behalf of the Australian Ovarian Cancer Study Group
Original Article



Women with advanced ovarian cancer generally have a poor prognosis but there is significant variability in survival despite similar disease characteristics and treatment regimens. The aim of this study was to determine whether psychosocial factors predict survival in women with ovarian cancer, controlling for potential confounders.


The sample comprised 798 women with invasive ovarian cancer recruited into the Australian Ovarian Cancer Study and a subsequent quality of life study. Validated measures of depression, optimism, minimization, helplessness/hopelessness, and social support were completed 3–6 monthly for up to 2 years. Four hundred nineteen women (52.5 %) died over the follow-up period. Associations between time-varying psychosocial variables and survival were tested using adjusted Cox proportional hazard models.


There was a significant interaction of psychosocial variables measured prior to first progression and overall survival, with higher optimism (adjusted hazard ratio per 1 standard deviation (HR) = 0.80, 95 % confidence interval (CI) 0.65–0.97), higher minimization (HR = 0.79, CI 0.66–0.94), and lower helplessness/hopelessness (HR = 1.40, CI 1.15–1.71) associated with longer survival. After disease progression, these variables were not associated with survival (optimism HR = 1.10, CI 0.95–1.27; minimization HR = 1.12, CI 0.95–1.31; and helplessness/hopelessness HR = 0.86, CI 0.74–1.00). Depression and social support were not associated with survival.


In women with invasive ovarian cancer, psychosocial variables prior to disease progression appear to impact on overall survival, suggesting a preventive rather than modifying role. Addressing psychosocial responses to cancer and their potential impact on treatment decision-making early in the disease trajectory may benefit survival and quality of life.


Ovarian cancer Oncology Psychological factors Survival Predictors 


  1. 1.
    Australian Institute of Health and Welfare & National Breast and Ovarian Cancer Centre. Ovarian Cancer in Australia: an overview, 2010. Canberra.Google Scholar
  2. 2.
    Coleman MP, Forman D, Bryant H, et al. (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377(9760):127–138. doi:10.1016/S0140-6736(10)62231-3 CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Parker PA, Baile WF, deMoor C, Cohen L (2003) Psychosocial and demographic predictors of quality of life in a large sample of cancer patients. Psycho-Oncology 12(2):183–193CrossRefPubMedGoogle Scholar
  4. 4.
    Punnen S, Cowan JE, Dunn LB, Shumay DM, Carroll PR, Cooperberg MR (2013) A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer. BJU International. 112(2):E67–E75. doi:10.1111/bju.12209 CrossRefPubMedGoogle Scholar
  5. 5.
    Antoni MH, Lechner S, Diaz A, et al. (2009) Cognitive behavioral stress management effects on psychosocial and physiological adaptation in women undergoing treatment for breast cancer. Brain Behav Immun 23(5):580–591. doi:10.1016/j.bbi. 2008.09.005 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Irwin ML, Mayne ST (2008) Impact of nutrition and exercise on cancer survival. Cancer J 14(6):435–441. doi:10.1097/PPO.0b013e31818daeee CrossRefPubMedGoogle Scholar
  7. 7.
    Watson M, Homewood J, Haviland J (2012) Coping response and survival in breast cancer patients: a new analysis. Stress Health 28(5):376–380. doi:10.1002/smi.2459 CrossRefPubMedGoogle Scholar
  8. 8.
    Carver CS, Scheier MF, Segerstrom SC (2010) Optimism. Clin Psychol Rev 30(7):879–889CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Antoni MH, Lutgendorf SK, Cole SW, et al. (2006) The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer 6(3):240–248. doi:10.1038/nrc1820 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Antoni MH. Psychosocial intervention effects on adaptation, disease course and biobehavioral processes in cancer. Brain Behav Immun. 2013; 30(SI):S88-S98. doi:10.1016/j.bbi. 2012.05.009Google Scholar
  11. 11.
    Butow P, Coates AS, Dunn SM (1999) Psychosocial predictors of survival in metastatic melanoma. J Clin Oncol 17(7):2256–2263. doi:10.1054/bjoc. 2000.1471 PubMedGoogle Scholar
  12. 12.
    Brown JE, Butow PN, Culjak G, Coates AS, Dunn SM (2000) Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanoma. Br J Cancer 83(11):1448–1453. doi:10.1054/bjoc. 2000.1471 CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Butow P, Coates AS, Dunn SM (2000) Psychosocial predictors of survival: metastatic breast cancer. Ann Oncol 11(4):469–474. doi:10.1038/sj.bjc.6603091 CrossRefPubMedGoogle Scholar
  14. 14.
    Butow PN, Brown JE, Coates AS, Dunn SM (2001) Psychosocial predictors of outcome IV: patients with early-stage breast cancer. Breast 10(Suppl 3):182–189CrossRefGoogle Scholar
  15. 15.
    Petticrew M, Bell R, Hunter D (2002) Influence of psychological coping on survival and recurrence in people with cancer: systematic review. BMJ 325(7372):1066. doi:10.1136/bmj.325.7372.1066 CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Kroenke CH, Kubzansky LD, Schernhammer ES, Holmes MD, Kawachi I (2006) Social networks, social support, and survival after breast cancer diagnosis. J Clin Oncol 24(7):1105–1111. doi:10.1200/JCO. 2005.04.2846 CrossRefPubMedGoogle Scholar
  17. 17.
    Chida Y, Hamer M, Wardle J, Steptoe A (2008) Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Rev Clin Oncol 5:466–475. doi:10.1038/ncponc1134 CrossRefGoogle Scholar
  18. 18.
    Satin JR, Linden W, Phillips MJ (2009) Depression as a predictor of disease progression and mortality in cancer patients. Cancer 115(22):5349–5361. doi:10.1002/cncr.24561 CrossRefPubMedGoogle Scholar
  19. 19.
    Dahl AA (2010) Link between personality and cancer. Future Oncol 6(5):691–707. doi:10.2217/fon.10.31 CrossRefPubMedGoogle Scholar
  20. 20.
    Martin Pinquarta M, Dubersteinb PR (2010) Associations of social networks with cancer mortality: a meta-analysis. Crit Rev Oncol Hematol 75(2):122–137. doi:10.1016/j.critrevonc. 2009.06.003 CrossRefGoogle Scholar
  21. 21.
    Lutgendorf SK, De Geest K, Bender D, et al. (2012) Social influences on clinical outcomes of patients with ovarian cancer. J Clin Oncol 30(23):2885–2890. doi:10.1200/JCO. 2011.39.4411 CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Spiegel D, Butler LD, Giese-Davis J, et al. (2007) Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: a randomized prospective trial. Cancer 110(5):1130–1138. doi:10.1002/cncr.22890 CrossRefPubMedGoogle Scholar
  23. 23.
    Kissane D, Li Y (2008) Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: a randomized prospective trial. Cancer 112(2):443–444. doi:10.1002/cncr.23179 CrossRefPubMedGoogle Scholar
  24. 24.
    Kissane D (2009) Beyond the psychotherapy and survival debate: the challenge of social disparity, depression and treatment adherence in psychosocial cancer care. Psycho-Oncology 18(1):1–5. doi:10.1002/pon.1493 CrossRefPubMedGoogle Scholar
  25. 25.
    Spiegel D (2012) Mind matters in cancer survival. Psycho-Oncology 21(6):588–593. doi:10.1002/pon.3067 CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Lutgendorf SK, Sood AK, Anderson B, et al. (2005) Social support, psychological distress, and natural killer cell activity in ovarian cancer. J Clin Oncol 23(28):7105–7113. doi:10.1200/JCO. 2011.39.4411 CrossRefPubMedGoogle Scholar
  27. 27.
    Costanzo ES, Lutgendorf SK, Sood AK, Anderson B, Sorosky J, Lubaroff DM (2005) Psychosocial factors and interleukin-6 among women with advanced ovarian cancer. Cancer 104(2):305–313. doi:10.1002/cncr.21147 CrossRefPubMedGoogle Scholar
  28. 28.
    Jordan SJ, Green AC, Whiteman DC, et al. (2008) Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis. Int J Cancer 122:1598–1603. doi:10.1002/ijc.23287 CrossRefPubMedGoogle Scholar
  29. 29.
    Price MA, Zachariae R, Butow PN, et al. (2009) Prevalence and predictors of insomnia in women with invasive ovarian cancer: anxiety a major factor. Eur J Cancer 45(18):3262–3270. doi:10.1016/j.ejca. 2009.05.030 CrossRefPubMedGoogle Scholar
  30. 30.
    Price MA, Butow PN, Costa DS, et al. (2010) Prevalence and predictors of anxiety and depression in women with invasive ovarian cancer and their carers. Med J Aust 193(5 Suppl):S52–S57PubMedGoogle Scholar
  31. 31.
    Rustin GJS, Vergote I, Eisenhauer E, et al. (2011) Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG). Int J Gynecol Cancer 21(2):419–423. doi:10.1097/IGC.0b013e3182070f17 CrossRefPubMedGoogle Scholar
  32. 32.
    Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica. 67(6):361–370. doi:10.1111/j.1600-0447.1983.tb09716.x CrossRefPubMedGoogle Scholar
  33. 33.
    Osborne RH, Elsworth GR, Kissane DW, Burke SA, Hopper JL (1999) The Mental Adjustment to Cancer (MAC) scale: replication and refinement in 632 breast cancer patients. Psychol Med 29(6):1335–1145. doi:10.1200/JCO. 2014.57.6801 CrossRefPubMedGoogle Scholar
  34. 34.
    Watson M, Greer S, Young J, Inayat Q, Burgess C, Robertson B (1988) Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med 18(1):203–209. doi:10.1017/S0033291700002026 CrossRefPubMedGoogle Scholar
  35. 35.
    Scheier MF, Carver CS, Bridges MW (1994) Distinguishing optimism from neuroticism (and trait anxiety, self mastery, and self esteem): a reevaluation of the life orientation test. J Pers Soc Psychol 67(6):1063–78. doi:10.1037/0022-3514.67.6.1063
  36. 36.
    Broadhead WE, Gehbach SH, de Gruy FV, Kaplan BH (1988) The Duke-UNC Functional Social Support Questionnaire. Measurement of social support in family medicine patients. Med Care 26(7):709–723CrossRefPubMedGoogle Scholar
  37. 37.
    Garssen B (2004) Psychological factors and cancer development: evidence after 30 years of research. Clin Psychol Rev 24(3):315–338. doi:10.1016/j.cpr. 2004.01.002 CrossRefPubMedGoogle Scholar
  38. 38.
    Danhauer SC, Crawford SL, Farmer DF, Avis NE (2009) A longitudinal investigation of coping strategies and quality of life among younger women with breast cancer. J Behav Med 32(4):371–379. doi:10.1007/s10865-009-9211-x CrossRefPubMedGoogle Scholar
  39. 39.
    Goncalves V, Jayson G, Tarrier N (2008) A longitudinal investigation of psychological morbidity in patients with ovarian cancer. Br J Cancer 99(11):1794–1801. doi:10.1038/sj.bjc.6604770 CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Australian Cancer Network and National Breast Cancer Centre. Clinical practice guidelines for the management of women with epithelial ovarian cancer. Camperdown, Sydney, Australia: National Breast Cancer Centre; 2004.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Melanie A. Price
    • 1
    • 2
  • Phyllis N. Butow
    • 1
    • 2
  • Melanie L. Bell
    • 2
    • 3
  • Anna deFazio
    • 4
  • Michael Friedlander
    • 5
    • 6
  • Joanna E. Fardell
    • 2
  • Melinda M. Protani
    • 7
  • Penelope M. Webb
    • 7
  • AOCS—Quality of Life Study Investigators on behalf of the Australian Ovarian Cancer Study Group
    • 1
    • 2
    • 4
    • 7
  1. 1.Centre for Medical Psychology and Evidence-based Decision-making (CeMPED), School of PsychologyThe University of SydneySydneyAustralia
  2. 2.Psycho-oncology Co-operative Research Group (PoCoG)The University of SydneySydneyAustralia
  3. 3.Division of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public HealthUniversity of ArizonaTucsonUSA
  4. 4.Department of Gynaecological Oncology, Westmead Hospital and Westmead Institute for Cancer ResearchThe University of Sydney at Westmead Millennium InstituteWestmeadAustralia
  5. 5.Prince of Wales Clinical SchoolUniversity of New South WalesSydneyAustralia
  6. 6.Department of Medical OncologyPrince of Wales HospitalRandwickAustralia
  7. 7.Gynaecological Cancers GroupQIMR Berghofer Medical Research InstituteBrisbaneAustralia

Personalised recommendations